Table 1:
All patients (N=1519) | Rectal swab and stool specimen (N=1142) | Rectal swab only (N=372) | Stool specimen only (N=5) | |||||
---|---|---|---|---|---|---|---|---|
n | Value | n | Value | n | Value | n | Value | |
Age (years) | 1519 | 1·6 (0·94–3·30) | 1142 | 1·5 (0·87–2·88) | 372 | 2·1 (1·10–4·50) | 5 | 1·4 (0·86–4·20) |
Enrolled in emergency department | 1519 | 1245 (82%) | 1142 | 882 (77%) | 372 | 361 (97%) | 5 | 2 (40%) |
Vomiting | 1511 | 1342 (89%) | 1136 | 998 (88%) | 371 | 341 (92%) | 4 | 3 (75%) |
Number of vomiting episodes in previous 24 h* | 1338 | 5 (3–8) | 994 | 4 (2–8) | 341 | 6 (3–10) | 3 | 4 (range 1–5) |
Vomiting duration at time of enrolment (h)* | 1341 | 38·0 (13·6–76·9) | 998 | 39·9 (14·7–78·6) | 340 | 32·1 (11·9–68·7) | 3 | 33·7 (range 11·8–36·3) |
Diarrhoea | 1511 | 1015 (67%) | 1136 | 812 (72%) | 371 | 199 (54%) | 4 | 4 (100%) |
Number of diarrhoea episodes in previous 24 h† | 1014 | 4 (2–7) | 811 | 4 (2–7) | 199 | 4 (2–7) | 4 | 7 (6–32) |
Diarrhoea duration at time of enrolment (h)† | 1013 | 52·5 (22·9–93·0) | 810 | 53·7 (24·3–95·2) | 199 | 45·6 (18·1–88·6) | 4 | 34·0 (31·9–42·1) |
Received rotavirus vaccine | 1511 | 425 (28%) | 1136 | 322 (28%) | 371 | 101 (27%) | 4 | 2 (50%) |
Rectal swab dry | 1519 | 1512 (>99%) | NA | NA | NA | NA | NA | NA |
Rectal fecal swabs | 1519 | 1468 (97%) | NA | NA | NA | NA | NA | NA |
Stool specimen | 1519 | 1147 (76%) | NA | NA | NA | NA | NA | NA |
Data are median (IQR) or n (%), except where indicated. The cohort included all eligible children who submitted a rectal swab or a stool specimen, or both. NA=not applicable.
Among children who indicated presence of vomiting.
Among children who indicated presence of diarrhoea.